La Jolla teams with Stanford U. for delivery tech; EastGate, Toronto Western develop seizure spray;

> La Jolla Pharmaceutical Company ($LJPC) joined forces with Stanford University to develop delivery technology for its rare-disease pipeline. Release

> EastGate Acquisitions is collaborating with a neuorologist at Toronto Western Hospital, Peter Carlen, to help develop an intraoral lorazepam spray for treating acute and repetitive seizures. Release

> A low dose of the drug bortezomib helps oncolytic viruses kill cancer cells. Announcement

Suggested Articles

Kala Pharma's Eysuvis on Tuesday became the first and only corticosteroid approved to treat short-term signs and symptoms of dry eye disease.

Xeris scored an FDA fast track designation for its diazepam formulation, delivered via autoinjector, to treat acute repetitive seizures.

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.